=Paper=
{{Paper
|id=Vol-3415/paper-29
|storemode=property
|title=An ontology for Age-Related Macular Degeneration using ophthalmologists and language
models
|pdfUrl=https://ceur-ws.org/Vol-3415/paper-29.pdf
|volume=Vol-3415
|dblpUrl=https://dblp.org/rec/conf/swat4ls/GrozaMN23
}}
==An ontology for Age-Related Macular Degeneration using ophthalmologists and language
models==
An ontology for Age-Related Macular Degeneration
using ophthalmologists and language models
Adrian Groza1 , Anca Marginean1 and Simona Delia Nicoara2
1
Department of Computer Science, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania
2
Department of Ophthalmology, βIuliu Hatieganuβ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
Abstract
We aim to support monitoring of the current guidelines and scientific evidence in the management of
Age-Related Macular Degeneration (AMD) in order to augment retinal specialists to develop a clinically
oriented and consensual protocol for therapeutic approaches for AMD. First, we are engineering an
ontology for AMD retinal condition using information from literature, related medical ontologies and
domain knowledge from ophthalmologists. Second, we augment the knowledge engineer capabilities to
populate and enrich the ontology using structured knowledge extracted from medical literature with
the GPT-3 language model. Third, we perform reasoning to signal to the ophthalmologist differences or
inconsistencies among different clinical studies, protocols or therapeutic approaches.
Keywords
medical ontologies, age-related macular degeneration, conflict detection, reasoning
First, as an example of axioms from the AMD ontology, consider the classifications of AMD
in Table 1, where πΏπππππ·ππ’π ππ β‘ π·ππ’π ππ β ββππ πππ§π. β₯ 125ππ, πππππ’ππ·ππ’π ππ β‘ π·ππ’π ππ β
ββππ πππ§π. β₯ 63ππ β ββππ πππ§π. β₯ 63ππ, respectively ππππππ·ππ’π ππ β‘ π·ππ’π ππ β ββππ πππ§π. β€ 63ππ.
One issue is that these axioms do not always correspond to clinical practice. For instance an
eye with a drusen measured by an AI algorithm at 124ΞΌm (i.e. slightly below the 125ΞΌm limit)
is classified according to the definition as a πππππ’ππ·ππ’π ππ, and hence an πΈππππ¦π΄ππ·, but the
ophthalmologist still treats the disease as an πΌ ππ‘ππππππππ‘ππ΄ππ·. To map the clinical practice
we are also considering axioms in Fuzzy Description Logic. The AMD ontology reuses con-
cepts and relations from BioVerbNet (https://github.com/cambridgeltl/bioverbnet) and medical
ontologies, e.g.: (i) π΄ππ· β πΌ πβππππ‘πππ
ππ‘πππππ·π¦π π‘πππβπ¦ β ππππππππππ·ππ πππ π β π» π’ππππ·ππ πππ π; (ii)
πΌ πβππππ‘πππ
ππ‘πππππ·π¦π π‘πππβπ¦ β πΌ πβππππ‘πππ ππ‘ππππ’π π
ππ‘πππππ·ππ πππ π β π
ππ‘πππππ·ππ πππππ β πΈπ¦ππ·ππ πππππ.
Second, we enrich the AMD ontology with structured data automatically extracted from
scientific studies [1] and clinical trials. Recent advances in Natural Language Understanding
can complement the studies conducted by humans on reviewing literature and recent scientific
evidence (e.g. [2]). Consider querying a learned model like GPT-3 (https://bit.ly/3e3icZQ) in
Table 2). The used prompt was: βA table summarizing the associations of morphological
features with disease activityβ. One the one hand we were fascinated on the easiness to obtain
such structured data. On the other hand, in line with G. Marcus (https://cacm.acm.org/blogs/
SWAT4HCLS 2023: The 14th International Conference on Semantic Web Applications and Tools for Health Care and Life
Sciences
Envelope-Open adrian.groza@cs.utcluj.ro (A. Groza)
GLOBE http://users.utcluj.ro/~agroza/ (A. Groza)
Orcid 0000-0003-0143-5631 (A. Groza)
Β© 2023 Copyright for this paper by its authors. Use permitted under Creative Commons License Attribution 4.0 International (CC BY 4.0).
CEUR
Workshop
Proceedings
http://ceur-ws.org
ISSN 1613-0073
CEUR Workshop Proceedings (CEUR-WS.org)
Table 1
Sample of definitions and classifications scales for AMD
Epidemiological classification (Wisconsin grading)
πΈππππ¦π΄ππ· π β‘ π΄ππ· β ββππ π΅ππππππππ.(πΏπππππ·ππ’π ππ β π
ππ‘ππππππ ππ’πππππ’π ππβ
πππππππ‘πππ¦π΄ππ)
πΏππ‘ππ΄ππ· π β‘ π πππ£ππ ππ’ππππ΄ππ· β πΊππππππβπππ΄π‘ππππ¦
Basic clinical classification
π ππ΄ππππππΆβπππππ πΆ β‘ ββππ π·ππ’π ππ.β₯ β ββππ π΄ππ.Β¬πππππππ‘πππ¦π΄ππ
π ππππππ΄ππππππΆβπππππ πΆ β‘ ββππ π·ππ’π ππ.ππππππ·ππ’π ππ β ββππ π΄ππ.Β¬πππππππ‘πππ¦π΄π
AREDS simplified severity scale points
πππ£ππππ‘π¦0 β‘ ββππ π΅ππππππππ.Β¬πΏπππππ·ππ’π ππ β βπβπππππ .Β¬πππππππ‘
πππ£ππππ‘π¦1 β‘ ββππ π΅ππππππππ.Β¬πΏπππππ·ππ’π ππ β (= 1)πβπππππ .πππππππ‘
Table 2
Extracting structured information on morphological features using language models (i.e. GPT3)
Review Feature Association with disease activity
Mowatt et al. (2014) OCT unlikely to be cost-effective for diagnosis/monitoring
Schmid-Erfurth et al. (2016) CRT inferior prognostic biomarker for guiding retreatment
Schmid-Erfurth et al. (2016) IRF negatively associated with VA
Schmid-Erfurth et al. (2016) SRF associated with superior visual benefits and a lower rate
of progression towards atrophy
blog-cacm/267674-ais-jurassic-park-moment/fulltext), we are aware of the risks that such
models to propagate misinformation. Our stance is that it is easier for the human agent to
verify the information in Table 2 and to annotate it with provenance data, instead of manually
collecting it from literature. From the technical perspective, the burden is how to feed the GPT-3
with relevant βpromptsβ (e.g. based on BioVerbNet) to get relevant information. In line with
C. Baquero (https://bit.ly/3ElW1J7, prompt design was critical for querying of such language
models. The job of Prompt Designer may become relevant in populating ontologies.
Third, we apply reasoning to signal differences and inconsistencies among the knowledge
within the ontology. These differences reflect the current understanding of the AMD disease:
quantitative vs. qualitative fluid assessments, intraretinal fluid vs. subretinal fluid (SRF),
exudative vs. nonexudtive fluid. For instance, for SRF both negative and positive but also
no-association have been reported [2]. Moreover, heterogeneity of therapeutic approaches has
been increased in the context of personalised care. This heterogeneity rises the question of
inconsistent information, detected in our approach by the Racer reasoning tool.
References
[1] P. Mitchell, G. Liew, B. Gopinath, T. Y. Wong, Age-related macular degeneration, The
Lancet 392 (2018) 1147β1159. doi:https://doi.org/10.1016/S0140- 6736(18)31550- 2 .
[2] L. Kodjikian, M. Parravano, A. Clemens, , et al., Fluid as a critical biomarker in neovas-
cular age-related macular degeneration management: literature review and consensus
recommendations, Eye 35 (2021) 2119β2135.